| Active principles | Rating | Bibliogr. | Expand |
---|
1 | Smallpox Vaccine | 100 | + | |
2 | Vaccines, Synthetic | 34 | + | |
3 | Viral Vaccines | 24 | + | |
4 | Viral Proteins | 22 | + | |
5 | Viral Envelope Proteins | 20 | + | |
6 | Antibodies, Viral | 19 | + | |
7 | AIDS Vaccines | 16 | + | |
8 | Vaccines, DNA | 15 | + | |
9 | Methisazone | 15 | + | |
10 | Gene Products, env | 14 | + | |
11 | Gene Products, gag | 12 | + | |
12 | Cytosine | 11 | + | |
13 | HIV Envelope Protein gp160 | 11 | + | |
14 | SAIDS Vaccines | 10 | + | |
15 | Vaccines, Attenuated | 10 | + | |
16 | Membrane Glycoproteins | 9 | + | |
17 | Thiosemicarbazones | 8 | + | |
18 | Viral Structural Proteins | 8 | + | |
19 | HIV Antibodies | 8 | + | |
20 | gag Gene Products, Human Immunodeficiency Virus | 8 | + | |
21 | Oncogene Proteins, Viral | 7 | + | |
22 | Lysosome-Associated Membrane Glycoproteins | 7 | + | |
23 | Interferon-gamma | 7 | + | |
24 | Antibodies, Neutralizing | 7 | + | |
25 | HIV Envelope Protein gp120 | 6 | + | |
26 | Antigens, CD58 | 6 | + | |
27 | Papillomavirus E7 Proteins | 6 | + | |
28 | HN Protein | 6 | + | |
29 | Recombinant Fusion Proteins | 6 | + | |
30 | Organophosphorus Compounds | 6 | + | |
31 | Cord Factors | 6 | + | |
32 | Cancer Vaccines | 6 | + | |
33 | Organophosphonates | 6 | + | |
34 | DNA, Recombinant | 6 | + | |
35 | Fusion Proteins, gag-pol | 6 | + | |
36 | Immunoglobulin Constant Regions | 6 | + | |
37 | Interferon-Stimulated Gene Factor 3 | 6 | + | |
38 | HLA-A2 Antigen | 6 | + | |
39 | Nigericin | 6 | + | |
40 | Gene Products, nef | 6 | + | |
41 | Malaria Vaccines | 5 | + | |
42 | HLA-A Antigens | 5 | + | |
43 | RNA-Binding Proteins | 5 | + | |
44 | Viral Fusion Proteins | 5 | + | |
45 | HLA-A1 Antigen | 5 | + | |
46 | env Gene Products, Human Immunodeficiency Virus | 5 | + | |
47 | Retroviridae Proteins | 5 | + | |
48 | Protozoan Proteins | 5 | + | |
49 | Viral Matrix Proteins | 5 | + | |
50 | Antibodies, Protozoan | 5 | + | |
51 | Oligonucleotide Probes | 5 | + | |
52 | Antigens, CD80 | 5 | + | |
53 | Idoxuridine | 5 | + | |
54 | Rabies Vaccines | 5 | + | |
55 | Protozoan Vaccines | 5 | + | |
56 | Aurintricarboxylic Acid | 4 | + | |
57 | Hemagglutinins, Viral | 4 | + | |
58 | Propanols | 4 | + | |
59 | Cell Wall Skeleton | 4 | + | |
60 | Vaccines | 4 | + | |
61 | beta-Galactosidase | 4 | + | |
62 | Herpesvirus Vaccines | 4 | + | |
63 | Repressor Proteins | 4 | + | |
64 | nef Gene Products, Human Immunodeficiency Virus | 4 | + | |
65 | Interleukin-2 | 4 | + | |
66 | Firefly Luciferin | 4 | + | |
67 | Isoindoles | 4 | + | |
68 | Interleukin-15 | 4 | + | |
69 | Recombinant Proteins | 3 | + | |
70 | DNA, Viral | 3 | + | |
71 | Yellow Fever Vaccine | 3 | + | |
72 | Gene Products, pol | 3 | + | |
73 | Retroelements | 3 | + | |
74 | Mucin-1 | 3 | + | |
75 | Ethacrynic Acid | 3 | + | |
76 | Vaccines, Subunit | 3 | + | |
77 | Viral Core Proteins | 3 | + | |
78 | Membrane Proteins | 3 | + | |
79 | Cyclin T | 3 | + | |
80 | Cytokines | 3 | + | |
81 | MART-1 Antigen | 3 | + | |
82 | Calreticulin | 3 | + | |
83 | Receptors, Virus | 3 | + | |
84 | Histocompatibility Antigens Class I | 3 | + | |
85 | Poloxalene | 3 | + | |
86 | Histocompatibility Antigens Class II | 3 | + | |
87 | Complement System Proteins | 3 | + | |
88 | Nucleoproteins | 2 | + | |
89 | Lipid A | 2 | + | |
90 | Helminth Proteins | 2 | + | |
91 | Immunoglobulin G | 2 | + | |
92 | Adenosylhomocysteinase | 2 | + | |
93 | Carboxylic Acids | 2 | + | |
94 | Carcinoembryonic Antigen | 2 | + | |
95 | Perforin | 2 | + | |
96 | Immunoglobulin A | 2 | + | |
97 | Nucleocapsid Proteins | 2 | + | |
98 | Acyltransferases | 2 | + | |
99 | Ribonucleosides | 2 | + | |
100 | HIV Core Protein p24 | 2 | + | |
101 | Hemolysin Proteins | 2 | + | |
102 | BCG Vaccine | 2 | + | |
103 | Nucleosides | 2 | + | |
104 | Immunoglobulins | 2 | + | |
105 | Oligodeoxyribonucleotides | 2 | + | |
106 | Tuberculosis Vaccines | 2 | + | |
107 | Vaccines, Inactivated | 2 | + | |
108 | Interleukin-12 | 2 | + | |
109 | Poly I-C | 2 | + | |
110 | Antigens, CD86 | 2 | + | |
111 | Interferons | 2 | + | |
112 | Glucuronidase | 2 | + | |
113 | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | + | |
114 | Peptide Fragments | 2 | + | |
115 | Respiratory Syncytial Virus Vaccines | 2 | + | |
116 | Hemagglutinin Glycoproteins, Influenza Virus | 2 | + | |
117 | Viral Nonstructural Proteins | 1 | + | |
118 | Viral Hepatitis Vaccines | 1 | + | |
119 | Immune Sera | 1 | + | |
120 | Antibodies, Neoplasm | 1 | + | |
121 | Papillomavirus Vaccines | 1 | + | |
122 | Peptides | 1 | + | |
123 | Thymidine Kinase | 1 | + | |
124 | Antibodies, Monoclonal | 1 | + | |
125 | DNA-Binding Proteins | 1 | + | |
126 | Interleukin-4 | 1 | + | |
127 | Neoplasm Proteins | 1 | + | |
128 | Antibodies | 1 | + | |
129 | Carrier Proteins | 1 | + | |
130 | Influenza Vaccines | 1 | + | |